Cargando…
SARS-CoV-2 proteome microarray for COVID-19 patient sera profiling
The immunogenicity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) proteome is largely unknown. Here we describe a protocol for analyzing sera samples with SARS-CoV-2 proteome microarray. The proteins were expressed by either E. coli expression system or eukaryotic cell expression sy...
Autores principales: | Lai, Dan-yun, Jiang, He-wei, Li, Yang, Zhang, Hai-nan, Tao, Sheng-ce |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882418/ https://www.ncbi.nlm.nih.gov/pubmed/35310073 http://dx.doi.org/10.1016/j.xpro.2022.101238 |
Ejemplares similares
-
SARS-CoV-2 spike linear epitope scanning via a peptide microarray through sera profiling
por: Li, Yang, et al.
Publicado: (2021) -
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
por: Jiang, He-wei, et al.
Publicado: (2020) -
Profiling of SARS‐CoV‐2 neutralizing antibody‐associated antigenic peptides signature using proteome microarray
por: Wu, Mingkun, et al.
Publicado: (2023) -
Autoantibody Profiling on Human Proteome Microarray for Biomarker Discovery in Cerebrospinal Fluid and Sera of Neuropsychiatric Lupus
por: Hu, Chaojun, et al.
Publicado: (2015) -
Systematic profiling of SARS-CoV-2-specific IgG epitopes at amino acid resolution
por: Qi, Huan, et al.
Publicado: (2021)